# Triana Biomedicines funding rounds and investors

As of 14 Oct 2026, Triana Biomedicines has raised $120M across 1 verified round on record; latest: $120 million Series B led by Ascenta Capital and Bessemer Venture Partners, announced 3 Dec 2025.

Trianabio sells novel biopharmaceutical therapeutics focused on utilizing molecular glues to treat previously undruggable diseases, primarily targeting cancer.

Website: https://trianabio.com  
Headquarters: Lexington, MA  
Page: https://fireround.dev/companies/trianabio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-12-03 | Series B | $120 million | Ascenta Capital, Bessemer Venture Partners | Atlas Ventures, Finchley Healthcare Ventures, Invus, Lightspeed, Pfizer Ventures, RA Capital Management, Regeneron Ventures, Surveyor Capital (a Citadel company), YK Bioventures | [trianabio.com](https://trianabio.com/press-release-12032025-1), [fiercebiotech.com](https://www.fiercebiotech.com/biotech/pfizer-backed-triana-scores-120m-series-b-take-molecular-glue-degrader-clinic) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.